Clinical Trials Logo

Clinical Trial Summary

To investigate a number of blood based parameters in patients with intestinal ischaemia compared to patients with other acute abdominal diseases.


Clinical Trial Description

Intestinal ischemia is a life-threatening condition defined by interrupted blood supply to the intestinal tissue. Primary and secondary ischemia is obstruction of blood-supply due to vascular and extra-vascular pathology, respectively. Early diagnosis and treatment are critical to save the ischemic bowel. Clinical findings of secondary intestinal ischaemia are related to the underlying cause e.g. vomiting and palpable hernia. Abdominal computed tomography (CT) can effectively visualize the causes. In contrast, the diagnosis of primary intestinal ischemia is often delayed due to the absence of specific clinical findings. Primary intestinal ischemia is visualized with CT ateriography, revealing mesentery arterial obstruction. However, in the acute setting a non-arterial phase CT is often performed but the findings are unspecific in the early stages and the pattern of findings which could indicate primary ischemia are not well understood. In primary and secondary ischemia, standard blood-based parameters are inconsistently elevated and highly unspecific. Newer blood-based parameters such as D-lactate has been proposed as ischaemic markers. D-lactate is produced by bacteria in the bowel lumen and translocation through a damaged bowel wall makes it a potential marker of intestinal ischemia. A case-control-study of all acute admitted patients with abdominal pain in Aalborg, Denmark in the mentioned time range. The sensitivity and specificity of potiential biomarkers in a blood sample at time of admission as a marker of intestinal ischaemia will be examined. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05665946
Study type Observational
Source Aalborg University Hospital
Contact
Status Completed
Phase
Start date January 6, 2015
Completion date March 24, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05194527 - The Detrimental Course of Acute Intestinal Ischemia
Not yet recruiting NCT06387147 - ORal Antibiotics In Acute Mesenteric Ischemia Phase 3
Completed NCT04867499 - Epidemiology of Acute Mesenteric Ischemia
Not yet recruiting NCT06212921 - Biomarkers in Prediction of AMI N/A
Recruiting NCT03518099 - Searching Biomarkers of Acute Intestinal Ischemic Injuries N/A
Not yet recruiting NCT06428240 - Acute Mesenteric Ischemia, Reality in Catalonia
Active, not recruiting NCT06365827 - Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)
Recruiting NCT06445660 - The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
Completed NCT05218863 - Incidence, Diagnosis, Management and Outcome of Acute Mesenteric Ischemia
Completed NCT05706012 - Antithrombotic Management of Acute Mesenteric Ischaemia
Not yet recruiting NCT06310395 - Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years
Recruiting NCT01788904 - Plasma i-FABP as Predictor for Irreversible Bowel Ischemia N/A
Recruiting NCT02772913 - Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study N/A